A Phase 3b, Multicenter, Multi-Country, Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of Orforglipron in Adult Participants with Type 2 Diabetes Who Observe Ramadan Fasting (ACHIEVE-RAM)
2026-09-14
عنوان الدراسة
A Phase 3b, Multicenter, Multi-Country, Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of Orforglipron in Adult Participants with Type 2 Diabetes Who Observe Ramadan Fasting (ACHIEVE-RAM)
داعم الدراسة
Eli Lilly and Company
دواء الدراسة
Orforglipron
رقم بروتوكول الدراسة
J2A-MC-GZPV
حالة الدراسة
Ongoing
موقع الدراسة
1.King Saud University Medical City - Riyadh 2.Imam Abdulrahman Bin Faisal University - Dammam 3.King Abdulaziz University Hospital - Jeddah 4.King Fahad Specialist Hospital - Dammam
مرحلة الدراسة
3b
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.